| 33722-0 | CAP cancer protocols Collection method |
| 33727-9 | Macroscopic tumor configuration (cap cancer protocols) |
| 33734-5 | Surgical margin tumor involvement.proximal (cap cancer protocols) |
| 33735-2 | Surgical margin tumor involvement.distant (cap cancer protocols) |
| 33736-0 | Surgical margin tumor involvement.circumferential (cap cancer protocols) |
| 33739-4 | Lymphatic.small vessel.invasion in Specimen (cap cancer protocols) |
| 33740-2 | Venous.large vessel.invasion in Specimen (cap cancer protocols) |
| 33741-0 | Perineural invasion in Specimen (cap cancer protocols) |
| 33743-6 | Intratumoral /Peritumoral lymphocytic response (cap cancer protocols) |
| 33744-4 | Additional pathological findings (cap cancer protocols) |
| 33749-3 | Distance from anal verge unknown (cap cancer protocols) |
| 33750-1 | Margins cannot be assessed (cap cancer protocols) |
| 33751-9 | Surgical margin tumor involvement.lateral in Specimen (cap cancer protocols) |
| 33753-5 | Lateral margin location (cap cancer protocols) |
| 33754-3 | Surgical margin tumor involvement.deep in Specimen (cap cancer protocols narrative) |
| 33758-4 | Polyp stalk length (cap cancer protocols) |
| 33760-0 | Surgical margin tumor involvement.mucosal in Specimen (cap cancer protocols) |
| 33761-8 | Venous + Lymphatic small vessel invasion in Specimen (cap cancer protocols) |
| 44620-3 | Other quantitation (cap cancer protocols) |
| 44621-1 | Regional lymph nodes examined (cap cancer protocols) |
| 44622-9 | Regional lymph nodes containing metastases (cap cancer protocols) |
| 44623-7 | Matted nodes (cap cancer protocols) |
| 44625-2 | Periprostatic fat invasion in Specimen (cap cancer protocols) |
| 44626-0 | Seminal vesicle invasion in Specimen (cap cancer protocols) |
| 44627-8 | Extraprostatic extension (cap cancer protocols) |
| 44632-8 | Satellite nodule presence (cap cancer protocols) |
| 44644-3 | Tubule formation in Breast tumor (qualitative, cap cancer protocols) |
| 44646-8 | Nottingham mitotic count.25x obj in Breast tumor (cap cancer protocols) |
| 44647-6 | Nottingham mitotic count.40x obj in Breast tumor (cap cancer protocols) |
| 44653-4 | Tumor quantitation.incidental in Prostate tumor (cap cancer protocols) |
| 44660-9 | Tumor involvement (ulceration by cap cancer protocols) |
| 44663-3 | T classification in Breast tumor (cap cancer protocols) |
| 44664-1 | T classification in Prostate tumor (cap cancer protocols) |
| 44665-8 | T classification (cap cancer protocols) |
| 44666-6 | M stage of distant metastasis in Breast tumor Qualitative (qualitative, cap cancer protocols) |
| 44668-2 | M stage of distant metastasis Qualitative (qualitative, cap cancer protocols) |
| 44670-8 | Margin involvement in Prostate tumor (cap cancer protocols) |
| 44671-6 | Margin involvement (cap cancer protocols) |
| 44694-8 | Tumor regression (cap cancer protocols) |
| 44695-5 | Mitotic index (cap cancer protocols) |
| 44699-7 | Extent of margin involvement (cap cancer protocols) |
| 85349-9 | Lymph node response to neoadjuvant therapy in Cancer specimen (cap cancer protocols) |
| 85904-1 | Cancer pathology panel - Breast cancer specimen (cap cancer protocols) |
| 85905-8 | Cancer pathology panel - Colorectal cancer specimen (cap cancer protocols) |